CD8A and neoplasm: Tumor immune phenotype is another potential prognostic biomarker; prognosis for clear cell RCC worsens with cluster of differentiation 8–positive (CD8 +) T-cell infiltration into tumor tissue and checkpoint molecule expression [13].